Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


29.07.2024

1 AIDS
3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 BMC Neurol
1 BMJ
5 Clin Infect Dis
1 J Acquir Immune Defic Syndr
14 J Infect Dis
3 J Med Virol
1 J Virol
1 Lancet
2 Lancet Infect Dis
3 N Engl J Med
1 PLoS Comput Biol
12 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. KAMPOURI E, Damas J, Kusejko K, Ledergerber B, et al
    Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room.
    AIDS. 2024 Jul 25. doi: 10.1097/QAD.0000000000003983.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  2. SUGAWARA S, Lee E, Craemer M, Pruitt A, et al
    Knockdowns of CD3zeta chain in Primary NK Cells Illustrate Modulation of Antibody-Dependent Cellular Cytotoxicity against Human Immunodeficiency Virus-1.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2023.0114.
    PubMed         Abstract available

  3. GOVINDARAJ S, Ibegbu C, Ali SA, Babu H, et al
    IL-15/IL-15Ra synergies with IL-12 to induce functional CD8 T cells and NK cells during chronic SHIV infection.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2024.0043.
    PubMed         Abstract available

  4. MATSUDA EM, da Silva Santos JH, Ahagon CM, Lopes GISL, et al
    Transmitted antiretroviral drug resistance to Integrase Strand Transfer Inhibitors class in Sao Paulo metropolitan area, Brazil.
    AIDS Res Hum Retroviruses. 2024 Jul 23. doi: 10.1089/AID.2023.0127.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  5. SEMERE GEBREYESUS M, Wasmann RE, McIlleron H, Oladokun R, et al
    Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy.
    Antimicrob Agents Chemother. 2024 Jul 22:e0035424. doi: 10.1128/aac.00354.
    PubMed         Abstract available


    BMC Neurol

  6. OHIRA K, Hashimoto N, Kanai D, Inoue Y, et al
    Novel and characteristic radiological features of neurosyphilis: a case series.
    BMC Neurol. 2024;24:248.
    PubMed         Abstract available


    BMJ

  7. IACOBUCCI G
    UN agency calls for funding boost and political will to end AIDS by 2030.
    BMJ. 2024;386:q1647.
    PubMed        


    Clin Infect Dis

  8. JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
    Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
    Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
    PubMed         Abstract available

  9. KAUPPINEN KJ, Aho I, Sjoblom N, Tynninen O, et al
    Effect of Two Forms of Tenofovir on Duodenal Enterocytes - a Hypothesis for Different Effect of TDF and TAF on Body Weight and Plasma Lipids.
    Clin Infect Dis. 2024 Jul 23:ciae374. doi: 10.1093.
    PubMed         Abstract available

  10. MEYA DB, Nalintya E, Skipper CP, Kirumira P, et al
    Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With Human Immunodeficiency Virus (HIV)-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers.
    Clin Infect Dis. 2024 Jul 24:ciae266. doi: 10.1093.
    PubMed         Abstract available

  11. HIRUY H, Bala S, Byrne JM, Roche KG, et al
    FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
    Clin Infect Dis. 2024 Jul 24:ciae386. doi: 10.1093.
    PubMed         Abstract available

  12. DITZENBERGER GL, Lake JE, Kitch DW, Kantor A, et al
    Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
    Clin Infect Dis. 2024 Jul 24:ciae384. doi: 10.1093.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  13. LEONG TD, Nel J, Jamieson L, Osih R, et al
    A review and economic analysis of the dapivirine vaginal ring as HIV pre-exposure prophylaxis for women, to inform South African public-sector guidelines.
    J Acquir Immune Defic Syndr. 2024 Jul 25. doi: 10.1097/QAI.0000000000003496.
    PubMed         Abstract available


    J Infect Dis

  14. BLOOM N, Ramirez SI, Cohn H, Parikh UM, et al
    SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback.
    J Infect Dis. 2024 Jul 22:jiae371. doi: 10.1093.
    PubMed         Abstract available

  15. AUNG S, Novitsky V, Steingrimsson J, Gillani FS, et al
    Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004-2021.
    J Infect Dis. 2024 Jul 23:jiae344. doi: 10.1093.
    PubMed         Abstract available

  16. ALESSANDRINI J, Cox J, de Pokomandy A, Hart TA, et al
    Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men in Canada, 2017-2019.
    J Infect Dis. 2024 Jul 23:jiae345. doi: 10.1093.
    PubMed         Abstract available

  17. GILS T, Hella J, Jacobs BKM, Sossen B, et al
    A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT CD4 Advanced Disease test in seven countries.
    J Infect Dis. 2024 Jul 24:jiae374. doi: 10.1093.
    PubMed         Abstract available

  18. LANTZ A, Kiweewa Matovu F, Johnson R, Isingel E, et al
    Female genital tract host factors and tenofovir and lamivudine active metabolites.
    J Infect Dis. 2024 Jul 24:jiae372. doi: 10.1093.
    PubMed         Abstract available

  19. WILCOX CS, Herbert C, Wang C, Ma Y, et al
    Signals From Inflamed Perivascular Adipose Tissue Contribute to Small-Vessel Dysfunction in Women With Human Immunodeficiency Virus.
    J Infect Dis. 2024;230:67-77.
    PubMed         Abstract available

  20. ELLIOT ER, Polli JW, Patel P, Garside L, et al
    Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
    J Infect Dis. 2024;230:e34-e42.
    PubMed         Abstract available

  21. ALLEN LI, Fraser H, Stone J, McAuley A, et al
    Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling Study.
    J Infect Dis. 2024;230:e48-e59.
    PubMed         Abstract available

  22. JOHNSON JA, Li JF, Politch JA, Lipscomb JT, et al
    HIV Immunocapture Reveals Particles Expressed in Semen Under Integrase Strand Transfer Inhibitor-Based Therapy Are Largely Myeloid Cell-Derived and Disparate.
    J Infect Dis. 2024;230:78-85.
    PubMed         Abstract available

  23. BURDORF RM, Zhou S, Amon C, Long N, et al
    Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.
    J Infect Dis. 2024;230:86-94.
    PubMed         Abstract available

  24. WANG X, Zhang Y, Xiao J, Song C, et al
    Effect of Vaginal Microecological Disorders on the Increased Risk of Abnormal Cervical Cytology Among Women With Human Immunodeficiency Virus in China.
    J Infect Dis. 2024;230:61-66.
    PubMed         Abstract available

  25. VAN DE WEG CAM, Thomazella MV, Marmorato MP, Correia CA, et al
    Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus.
    J Infect Dis. 2024;230:e60-e64.
    PubMed         Abstract available

  26. COMBES JD, Didelot JM, Radenne S, Zaegel-Faucher O, et al
    Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in France.
    J Infect Dis. 2024;230:55-60.
    PubMed         Abstract available

  27. VAN TEIJLINGEN NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al
    Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells.
    J Infect Dis. 2024;230:e43-e47.
    PubMed         Abstract available


    J Med Virol

  28. LI J, Lv J, Yu F, Zhang Y, et al
    Temporal changes in plasma metabolic signatures to predict immune response of antiretroviral therapy among people living with HIV.
    J Med Virol. 2024;96:e29798.
    PubMed         Abstract available

  29. MONTI B, Soria A, Saladini F, Lapadula G, et al
    Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests.
    J Med Virol. 2024;96:e29832.
    PubMed        

  30. GUPTA A, Righi E, Konnova A, Sciammarella C, et al
    Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.
    J Med Virol. 2024;96:e29820.
    PubMed         Abstract available


    J Virol

  31. NELSON GW, van Duijn J, Yuki Y, Pau MG, et al
    Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.
    J Virol. 2024 Jul 24:e0028124. doi: 10.1128/jvi.00281.
    PubMed         Abstract available


    Lancet

  32. KIRBY T
    Beatriz Grinsztejn: leading Brazil's response to HIV.
    Lancet. 2024;404:233.
    PubMed        


    Lancet Infect Dis

  33. LEHMANN C, Schommers P
    The need for novel approaches to HIV-1 vaccine development.
    Lancet Infect Dis. 2024 Jul 19:S1473-3099(24)00398.
    PubMed        

  34. GRAY GE, Mngadi K, Lavreys L, Nijs S, et al
    Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.
    Lancet Infect Dis. 2024 Jul 19:S1473-3099(24)00358.
    PubMed         Abstract available


    N Engl J Med

  35. MEINTJES G, Maartens G
    HIV-Associated Tuberculosis.
    N Engl J Med. 2024;391:343-355.
    PubMed        

  36. BEKKER LG, Das M, Abdool Karim Q, Ahmed K, et al
    Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMoa2407001.
    PubMed         Abstract available

  37. LANDOVITZ RJ, Delany-Moretlwe S, Fogel JM, Marzinke MA, et al
    Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMc2402088.
    PubMed        


    PLoS Comput Biol

  38. TATARA E, Lin Q, Ozik J, Kolak M, et al
    Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.
    PLoS Comput Biol. 2024;20:e1012307.
    PubMed         Abstract available


    PLoS One

  39. BIN AHMAD MZ, Md Yasin M, Mat Nasir N, Mohamad M, et al
    The association between HIV-related stigma, HIV knowledge and HIV late presenters among people living with HIV (PLHIV) attending public primary care clinic settings in Selangor.
    PLoS One. 2024;19:e0306904.
    PubMed         Abstract available

  40. EMMANUEL F, Aloo L, Mahfooz A, Nkuatsana M, et al
    Measuring HIV outcomes for adolescent girls and young women programs in Africa: Using the polling booth survey technique.
    PLoS One. 2024;19:e0307198.
    PubMed         Abstract available

  41. MAZZINI S, Borgonovo G, Princiotto S, Artali R, et al
    Quadruplex-duplex junction in LTR-III: A molecular insight into the complexes with BMH-21, namitecan and doxorubicin.
    PLoS One. 2024;19:e0306239.
    PubMed         Abstract available

  42. CAMERON MP, Newman PA, Chakrapani V, Shunmugam M, et al
    Stated preferences for new HIV prevention technologies among men who have sex with men in India: A discrete choice experiment.
    PLoS One. 2024;19:e0289396.
    PubMed         Abstract available

  43. SHI Y, Zhang J, Wang Z, Shan F, et al
    The association between alcohol consumption and herpes simplex virus type 2: A cross-sectional study from national health and nutrition examination survey 2009-2016.
    PLoS One. 2024;19:e0307702.
    PubMed         Abstract available

  44. WU Q, Tan J, Chen S, Wang J, et al
    Incidence and influencing factors related to social isolation among HIV/AIDS patients: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0307656.
    PubMed         Abstract available

  45. WU Y, Mattas E, Brandenburg C, Fusaris E, et al
    The association of sociodemographic characteristics and comorbidities with post-acute sequelae of SARS-CoV-2 in a Medicaid managed care population with and without HIV.
    PLoS One. 2024;19:e0306322.
    PubMed         Abstract available

  46. TATHAM C
    Life and love under criminalization: The experiences of people living with HIV in Canada.
    PLoS One. 2024;19:e0306894.
    PubMed         Abstract available

  47. IRFAN SD, Reza M, Khan MNM, Khan SI, et al
    Exploring and addressing the sexual and reproductive health and other related rights of transgender women in Bangladesh: A mixed methods protocol under the policy analysis framework.
    PLoS One. 2024;19:e0306051.
    PubMed         Abstract available

  48. CHAPARRO AI, Formul D, Vasquez S, Cianelli R, et al
    Breastfeeding in women with HIV infection: A qualitative study of barriers and facilitators.
    PLoS One. 2024;19:e0303788.
    PubMed         Abstract available

  49. OOSTERHOF P, Wit FWNM, van Luin M, van der Valk M, et al
    First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020.
    PLoS One. 2024;19:e0307963.
    PubMed         Abstract available

  50. UHAWENIMANA TC, Muganwa K, Uwimana MC, Musabwasoni MGS, et al
    Factors affecting the prevention of unwanted pregnancies among young adolescents in secondary schools in the Eastern Province of Rwanda: An explorative qualitative study.
    PLoS One. 2024;19:e0301248.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  51. ORTIZ Y, Anasti K, Pane AK, Cronin K, et al
    The CH1 domain influences the expression and antigen sensing of the HIV-specific CH31 IgM-BCR and IgG-BCR.
    Proc Natl Acad Sci U S A. 2024;121:e2404728121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.